Global Gastrointestinal Stromal Tumor Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 164

Published Date: 29 Jul 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Gastrointestinal Stromal Tumor Drug market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.

This report is a detailed and comprehensive analysis for global Gastrointestinal Stromal Tumor Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global Gastrointestinal Stromal Tumor Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Gastrointestinal Stromal Tumor Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Gastrointestinal Stromal Tumor Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Gastrointestinal Stromal Tumor Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Gastrointestinal Stromal Tumor Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Gastrointestinal Stromal Tumor Drug market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Bayer Pharmaceuticals, Glenmark Pharmaceuticals Ltd., Sun Pharmaceuticals, Actavis Generics, Dr. Reddy's Laboratories, Teva Pharmaceutical Industries Ltd., Apotex Inc., Mylan Pharms Inc., Bulat Pharmaceutical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation
Gastrointestinal Stromal Tumor Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Imatinib
    Sunitinib
    Regorafenib
    Ripretinib
    Others

Market segment by Application
    Hospital
    Clinic
    Others

Major players covered
    Novartis
    Bayer Pharmaceuticals
    Glenmark Pharmaceuticals Ltd.
    Sun Pharmaceuticals
    Actavis Generics
    Dr. Reddy's Laboratories
    Teva Pharmaceutical Industries Ltd.
    Apotex Inc.
    Mylan Pharms Inc.
    Bulat Pharmaceutical
    MSN Laboratories
    Vannsh Life Sciences
    Beacon Pharmaceuticals
    Drug International
    Deciphera Pharmaceuticals
    CSPC Pharmaceuticals
    Hansoh Pharmaceuticals
    Kelun Pharmaceuticals
    Zai Lab
    CStone Pharmaceuticals
    China Biopharmaceuticals

Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gastrointestinal Stromal Tumor Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Gastrointestinal Stromal Tumor Drug, with price, sales quantity, revenue, and global market share of Gastrointestinal Stromal Tumor Drug from 2019 to 2024.
Chapter 3, the Gastrointestinal Stromal Tumor Drug competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gastrointestinal Stromal Tumor Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Gastrointestinal Stromal Tumor Drug market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Gastrointestinal Stromal Tumor Drug.
Chapter 14 and 15, to describe Gastrointestinal Stromal Tumor Drug sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Gastrointestinal Stromal Tumor Drug Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Imatinib
        1.3.3 Sunitinib
        1.3.4 Regorafenib
        1.3.5 Ripretinib
        1.3.6 Others
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Gastrointestinal Stromal Tumor Drug Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hospital
        1.4.3 Clinic
        1.4.4 Others
    1.5 Global Gastrointestinal Stromal Tumor Drug Market Size & Forecast
        1.5.1 Global Gastrointestinal Stromal Tumor Drug Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Gastrointestinal Stromal Tumor Drug Sales Quantity (2019-2030)
        1.5.3 Global Gastrointestinal Stromal Tumor Drug Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Novartis
        2.1.1 Novartis Details
        2.1.2 Novartis Major Business
        2.1.3 Novartis Gastrointestinal Stromal Tumor Drug Product and Services
        2.1.4 Novartis Gastrointestinal Stromal Tumor Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Novartis Recent Developments/Updates
    2.2 Bayer Pharmaceuticals
        2.2.1 Bayer Pharmaceuticals Details
        2.2.2 Bayer Pharmaceuticals Major Business
        2.2.3 Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product and Services
        2.2.4 Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Bayer Pharmaceuticals Recent Developments/Updates
    2.3 Glenmark Pharmaceuticals Ltd.
        2.3.1 Glenmark Pharmaceuticals Ltd. Details
        2.3.2 Glenmark Pharmaceuticals Ltd. Major Business
        2.3.3 Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Drug Product and Services
        2.3.4 Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Glenmark Pharmaceuticals Ltd. Recent Developments/Updates
    2.4 Sun Pharmaceuticals
        2.4.1 Sun Pharmaceuticals Details
        2.4.2 Sun Pharmaceuticals Major Business
        2.4.3 Sun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product and Services
        2.4.4 Sun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Sun Pharmaceuticals Recent Developments/Updates
    2.5 Actavis Generics
        2.5.1 Actavis Generics Details
        2.5.2 Actavis Generics Major Business
        2.5.3 Actavis Generics Gastrointestinal Stromal Tumor Drug Product and Services
        2.5.4 Actavis Generics Gastrointestinal Stromal Tumor Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Actavis Generics Recent Developments/Updates
    2.6 Dr. Reddy's Laboratories
        2.6.1 Dr. Reddy's Laboratories Details
        2.6.2 Dr. Reddy's Laboratories Major Business
        2.6.3 Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Drug Product and Services
        2.6.4 Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Dr. Reddy's Laboratories Recent Developments/Updates
    2.7 Teva Pharmaceutical Industries Ltd.
        2.7.1 Teva Pharmaceutical Industries Ltd. Details
        2.7.2 Teva Pharmaceutical Industries Ltd. Major Business
        2.7.3 Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Drug Product and Services
        2.7.4 Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
    2.8 Apotex Inc.
        2.8.1 Apotex Inc. Details
        2.8.2 Apotex Inc. Major Business
        2.8.3 Apotex Inc. Gastrointestinal Stromal Tumor Drug Product and Services
        2.8.4 Apotex Inc. Gastrointestinal Stromal Tumor Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Apotex Inc. Recent Developments/Updates
    2.9 Mylan Pharms Inc.
        2.9.1 Mylan Pharms Inc. Details
        2.9.2 Mylan Pharms Inc. Major Business
        2.9.3 Mylan Pharms Inc. Gastrointestinal Stromal Tumor Drug Product and Services
        2.9.4 Mylan Pharms Inc. Gastrointestinal Stromal Tumor Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Mylan Pharms Inc. Recent Developments/Updates
    2.10 Bulat Pharmaceutical
        2.10.1 Bulat Pharmaceutical Details
        2.10.2 Bulat Pharmaceutical Major Business
        2.10.3 Bulat Pharmaceutical Gastrointestinal Stromal Tumor Drug Product and Services
        2.10.4 Bulat Pharmaceutical Gastrointestinal Stromal Tumor Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Bulat Pharmaceutical Recent Developments/Updates
    2.11 MSN Laboratories
        2.11.1 MSN Laboratories Details
        2.11.2 MSN Laboratories Major Business
        2.11.3 MSN Laboratories Gastrointestinal Stromal Tumor Drug Product and Services
        2.11.4 MSN Laboratories Gastrointestinal Stromal Tumor Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 MSN Laboratories Recent Developments/Updates
    2.12 Vannsh Life Sciences
        2.12.1 Vannsh Life Sciences Details
        2.12.2 Vannsh Life Sciences Major Business
        2.12.3 Vannsh Life Sciences Gastrointestinal Stromal Tumor Drug Product and Services
        2.12.4 Vannsh Life Sciences Gastrointestinal Stromal Tumor Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 Vannsh Life Sciences Recent Developments/Updates
    2.13 Beacon Pharmaceuticals
        2.13.1 Beacon Pharmaceuticals Details
        2.13.2 Beacon Pharmaceuticals Major Business
        2.13.3 Beacon Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product and Services
        2.13.4 Beacon Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 Beacon Pharmaceuticals Recent Developments/Updates
    2.14 Drug International
        2.14.1 Drug International Details
        2.14.2 Drug International Major Business
        2.14.3 Drug International Gastrointestinal Stromal Tumor Drug Product and Services
        2.14.4 Drug International Gastrointestinal Stromal Tumor Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.14.5 Drug International Recent Developments/Updates
    2.15 Deciphera Pharmaceuticals
        2.15.1 Deciphera Pharmaceuticals Details
        2.15.2 Deciphera Pharmaceuticals Major Business
        2.15.3 Deciphera Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product and Services
        2.15.4 Deciphera Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.15.5 Deciphera Pharmaceuticals Recent Developments/Updates
    2.16 CSPC Pharmaceuticals
        2.16.1 CSPC Pharmaceuticals Details
        2.16.2 CSPC Pharmaceuticals Major Business
        2.16.3 CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product and Services
        2.16.4 CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.16.5 CSPC Pharmaceuticals Recent Developments/Updates
    2.17 Hansoh Pharmaceuticals
        2.17.1 Hansoh Pharmaceuticals Details
        2.17.2 Hansoh Pharmaceuticals Major Business
        2.17.3 Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product and Services
        2.17.4 Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.17.5 Hansoh Pharmaceuticals Recent Developments/Updates
    2.18 Kelun Pharmaceuticals
        2.18.1 Kelun Pharmaceuticals Details
        2.18.2 Kelun Pharmaceuticals Major Business
        2.18.3 Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product and Services
        2.18.4 Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.18.5 Kelun Pharmaceuticals Recent Developments/Updates
    2.19 Zai Lab
        2.19.1 Zai Lab Details
        2.19.2 Zai Lab Major Business
        2.19.3 Zai Lab Gastrointestinal Stromal Tumor Drug Product and Services
        2.19.4 Zai Lab Gastrointestinal Stromal Tumor Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.19.5 Zai Lab Recent Developments/Updates
    2.20 CStone Pharmaceuticals
        2.20.1 CStone Pharmaceuticals Details
        2.20.2 CStone Pharmaceuticals Major Business
        2.20.3 CStone Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product and Services
        2.20.4 CStone Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.20.5 CStone Pharmaceuticals Recent Developments/Updates
    2.21 China Biopharmaceuticals
        2.21.1 China Biopharmaceuticals Details
        2.21.2 China Biopharmaceuticals Major Business
        2.21.3 China Biopharmaceuticals Gastrointestinal Stromal Tumor Drug Product and Services
        2.21.4 China Biopharmaceuticals Gastrointestinal Stromal Tumor Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.21.5 China Biopharmaceuticals Recent Developments/Updates

3 Competitive Environment: Gastrointestinal Stromal Tumor Drug by Manufacturer
    3.1 Global Gastrointestinal Stromal Tumor Drug Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Gastrointestinal Stromal Tumor Drug Revenue by Manufacturer (2019-2024)
    3.3 Global Gastrointestinal Stromal Tumor Drug Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Gastrointestinal Stromal Tumor Drug by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Gastrointestinal Stromal Tumor Drug Manufacturer Market Share in 2023
        3.4.3 Top 6 Gastrointestinal Stromal Tumor Drug Manufacturer Market Share in 2023
    3.5 Gastrointestinal Stromal Tumor Drug Market: Overall Company Footprint Analysis
        3.5.1 Gastrointestinal Stromal Tumor Drug Market: Region Footprint
        3.5.2 Gastrointestinal Stromal Tumor Drug Market: Company Product Type Footprint
        3.5.3 Gastrointestinal Stromal Tumor Drug Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Gastrointestinal Stromal Tumor Drug Market Size by Region
        4.1.1 Global Gastrointestinal Stromal Tumor Drug Sales Quantity by Region (2019-2030)
        4.1.2 Global Gastrointestinal Stromal Tumor Drug Consumption Value by Region (2019-2030)
        4.1.3 Global Gastrointestinal Stromal Tumor Drug Average Price by Region (2019-2030)
    4.2 North America Gastrointestinal Stromal Tumor Drug Consumption Value (2019-2030)
    4.3 Europe Gastrointestinal Stromal Tumor Drug Consumption Value (2019-2030)
    4.4 Asia-Pacific Gastrointestinal Stromal Tumor Drug Consumption Value (2019-2030)
    4.5 South America Gastrointestinal Stromal Tumor Drug Consumption Value (2019-2030)
    4.6 Middle East & Africa Gastrointestinal Stromal Tumor Drug Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Gastrointestinal Stromal Tumor Drug Sales Quantity by Type (2019-2030)
    5.2 Global Gastrointestinal Stromal Tumor Drug Consumption Value by Type (2019-2030)
    5.3 Global Gastrointestinal Stromal Tumor Drug Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Gastrointestinal Stromal Tumor Drug Sales Quantity by Application (2019-2030)
    6.2 Global Gastrointestinal Stromal Tumor Drug Consumption Value by Application (2019-2030)
    6.3 Global Gastrointestinal Stromal Tumor Drug Average Price by Application (2019-2030)

7 North America
    7.1 North America Gastrointestinal Stromal Tumor Drug Sales Quantity by Type (2019-2030)
    7.2 North America Gastrointestinal Stromal Tumor Drug Sales Quantity by Application (2019-2030)
    7.3 North America Gastrointestinal Stromal Tumor Drug Market Size by Country
        7.3.1 North America Gastrointestinal Stromal Tumor Drug Sales Quantity by Country (2019-2030)
        7.3.2 North America Gastrointestinal Stromal Tumor Drug Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Gastrointestinal Stromal Tumor Drug Sales Quantity by Type (2019-2030)
    8.2 Europe Gastrointestinal Stromal Tumor Drug Sales Quantity by Application (2019-2030)
    8.3 Europe Gastrointestinal Stromal Tumor Drug Market Size by Country
        8.3.1 Europe Gastrointestinal Stromal Tumor Drug Sales Quantity by Country (2019-2030)
        8.3.2 Europe Gastrointestinal Stromal Tumor Drug Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Gastrointestinal Stromal Tumor Drug Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Gastrointestinal Stromal Tumor Drug Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Gastrointestinal Stromal Tumor Drug Market Size by Region
        9.3.1 Asia-Pacific Gastrointestinal Stromal Tumor Drug Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Gastrointestinal Stromal Tumor Drug Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 South Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Gastrointestinal Stromal Tumor Drug Sales Quantity by Type (2019-2030)
    10.2 South America Gastrointestinal Stromal Tumor Drug Sales Quantity by Application (2019-2030)
    10.3 South America Gastrointestinal Stromal Tumor Drug Market Size by Country
        10.3.1 South America Gastrointestinal Stromal Tumor Drug Sales Quantity by Country (2019-2030)
        10.3.2 South America Gastrointestinal Stromal Tumor Drug Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Gastrointestinal Stromal Tumor Drug Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Gastrointestinal Stromal Tumor Drug Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Gastrointestinal Stromal Tumor Drug Market Size by Country
        11.3.1 Middle East & Africa Gastrointestinal Stromal Tumor Drug Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Gastrointestinal Stromal Tumor Drug Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Gastrointestinal Stromal Tumor Drug Market Drivers
    12.2 Gastrointestinal Stromal Tumor Drug Market Restraints
    12.3 Gastrointestinal Stromal Tumor Drug Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Gastrointestinal Stromal Tumor Drug and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Gastrointestinal Stromal Tumor Drug
    13.3 Gastrointestinal Stromal Tumor Drug Production Process
    13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Gastrointestinal Stromal Tumor Drug Typical Distributors
    14.3 Gastrointestinal Stromal Tumor Drug Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Gastrointestinal Stromal Tumor Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 2. Global Gastrointestinal Stromal Tumor Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 3. Novartis Basic Information, Manufacturing Base and Competitors
 Table 4. Novartis Major Business
 Table 5. Novartis Gastrointestinal Stromal Tumor Drug Product and Services
 Table 6. Novartis Gastrointestinal Stromal Tumor Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 7. Novartis Recent Developments/Updates
 Table 8. Bayer Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 9. Bayer Pharmaceuticals Major Business
 Table 10. Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product and Services
 Table 11. Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 12. Bayer Pharmaceuticals Recent Developments/Updates
 Table 13. Glenmark Pharmaceuticals Ltd. Basic Information, Manufacturing Base and Competitors
 Table 14. Glenmark Pharmaceuticals Ltd. Major Business
 Table 15. Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Drug Product and Services
 Table 16. Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 17. Glenmark Pharmaceuticals Ltd. Recent Developments/Updates
 Table 18. Sun Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 19. Sun Pharmaceuticals Major Business
 Table 20. Sun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product and Services
 Table 21. Sun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 22. Sun Pharmaceuticals Recent Developments/Updates
 Table 23. Actavis Generics Basic Information, Manufacturing Base and Competitors
 Table 24. Actavis Generics Major Business
 Table 25. Actavis Generics Gastrointestinal Stromal Tumor Drug Product and Services
 Table 26. Actavis Generics Gastrointestinal Stromal Tumor Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 27. Actavis Generics Recent Developments/Updates
 Table 28. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
 Table 29. Dr. Reddy's Laboratories Major Business
 Table 30. Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Drug Product and Services
 Table 31. Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 32. Dr. Reddy's Laboratories Recent Developments/Updates
 Table 33. Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
 Table 34. Teva Pharmaceutical Industries Ltd. Major Business
 Table 35. Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Drug Product and Services
 Table 36. Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 37. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
 Table 38. Apotex Inc. Basic Information, Manufacturing Base and Competitors
 Table 39. Apotex Inc. Major Business
 Table 40. Apotex Inc. Gastrointestinal Stromal Tumor Drug Product and Services
 Table 41. Apotex Inc. Gastrointestinal Stromal Tumor Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 42. Apotex Inc. Recent Developments/Updates
 Table 43. Mylan Pharms Inc. Basic Information, Manufacturing Base and Competitors
 Table 44. Mylan Pharms Inc. Major Business
 Table 45. Mylan Pharms Inc. Gastrointestinal Stromal Tumor Drug Product and Services
 Table 46. Mylan Pharms Inc. Gastrointestinal Stromal Tumor Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 47. Mylan Pharms Inc. Recent Developments/Updates
 Table 48. Bulat Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 49. Bulat Pharmaceutical Major Business
 Table 50. Bulat Pharmaceutical Gastrointestinal Stromal Tumor Drug Product and Services
 Table 51. Bulat Pharmaceutical Gastrointestinal Stromal Tumor Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 52. Bulat Pharmaceutical Recent Developments/Updates
 Table 53. MSN Laboratories Basic Information, Manufacturing Base and Competitors
 Table 54. MSN Laboratories Major Business
 Table 55. MSN Laboratories Gastrointestinal Stromal Tumor Drug Product and Services
 Table 56. MSN Laboratories Gastrointestinal Stromal Tumor Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 57. MSN Laboratories Recent Developments/Updates
 Table 58. Vannsh Life Sciences Basic Information, Manufacturing Base and Competitors
 Table 59. Vannsh Life Sciences Major Business
 Table 60. Vannsh Life Sciences Gastrointestinal Stromal Tumor Drug Product and Services
 Table 61. Vannsh Life Sciences Gastrointestinal Stromal Tumor Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 62. Vannsh Life Sciences Recent Developments/Updates
 Table 63. Beacon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 64. Beacon Pharmaceuticals Major Business
 Table 65. Beacon Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product and Services
 Table 66. Beacon Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 67. Beacon Pharmaceuticals Recent Developments/Updates
 Table 68. Drug International Basic Information, Manufacturing Base and Competitors
 Table 69. Drug International Major Business
 Table 70. Drug International Gastrointestinal Stromal Tumor Drug Product and Services
 Table 71. Drug International Gastrointestinal Stromal Tumor Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 72. Drug International Recent Developments/Updates
 Table 73. Deciphera Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 74. Deciphera Pharmaceuticals Major Business
 Table 75. Deciphera Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product and Services
 Table 76. Deciphera Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 77. Deciphera Pharmaceuticals Recent Developments/Updates
 Table 78. CSPC Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 79. CSPC Pharmaceuticals Major Business
 Table 80. CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product and Services
 Table 81. CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 82. CSPC Pharmaceuticals Recent Developments/Updates
 Table 83. Hansoh Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 84. Hansoh Pharmaceuticals Major Business
 Table 85. Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product and Services
 Table 86. Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 87. Hansoh Pharmaceuticals Recent Developments/Updates
 Table 88. Kelun Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 89. Kelun Pharmaceuticals Major Business
 Table 90. Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product and Services
 Table 91. Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 92. Kelun Pharmaceuticals Recent Developments/Updates
 Table 93. Zai Lab Basic Information, Manufacturing Base and Competitors
 Table 94. Zai Lab Major Business
 Table 95. Zai Lab Gastrointestinal Stromal Tumor Drug Product and Services
 Table 96. Zai Lab Gastrointestinal Stromal Tumor Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 97. Zai Lab Recent Developments/Updates
 Table 98. CStone Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 99. CStone Pharmaceuticals Major Business
 Table 100. CStone Pharmaceuticals Gastrointestinal Stromal Tumor Drug Product and Services
 Table 101. CStone Pharmaceuticals Gastrointestinal Stromal Tumor Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 102. CStone Pharmaceuticals Recent Developments/Updates
 Table 103. China Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 104. China Biopharmaceuticals Major Business
 Table 105. China Biopharmaceuticals Gastrointestinal Stromal Tumor Drug Product and Services
 Table 106. China Biopharmaceuticals Gastrointestinal Stromal Tumor Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 107. China Biopharmaceuticals Recent Developments/Updates
 Table 108. Global Gastrointestinal Stromal Tumor Drug Sales Quantity by Manufacturer (2019-2024) & (K Units)
 Table 109. Global Gastrointestinal Stromal Tumor Drug Revenue by Manufacturer (2019-2024) & (USD Million)
 Table 110. Global Gastrointestinal Stromal Tumor Drug Average Price by Manufacturer (2019-2024) & (US$/Unit)
 Table 111. Market Position of Manufacturers in Gastrointestinal Stromal Tumor Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
 Table 112. Head Office and Gastrointestinal Stromal Tumor Drug Production Site of Key Manufacturer
 Table 113. Gastrointestinal Stromal Tumor Drug Market: Company Product Type Footprint
 Table 114. Gastrointestinal Stromal Tumor Drug Market: Company Product Application Footprint
 Table 115. Gastrointestinal Stromal Tumor Drug New Market Entrants and Barriers to Market Entry
 Table 116. Gastrointestinal Stromal Tumor Drug Mergers, Acquisition, Agreements, and Collaborations
 Table 117. Global Gastrointestinal Stromal Tumor Drug Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
 Table 118. Global Gastrointestinal Stromal Tumor Drug Sales Quantity by Region (2019-2024) & (K Units)
 Table 119. Global Gastrointestinal Stromal Tumor Drug Sales Quantity by Region (2025-2030) & (K Units)
 Table 120. Global Gastrointestinal Stromal Tumor Drug Consumption Value by Region (2019-2024) & (USD Million)
 Table 121. Global Gastrointestinal Stromal Tumor Drug Consumption Value by Region (2025-2030) & (USD Million)
 Table 122. Global Gastrointestinal Stromal Tumor Drug Average Price by Region (2019-2024) & (US$/Unit)
 Table 123. Global Gastrointestinal Stromal Tumor Drug Average Price by Region (2025-2030) & (US$/Unit)
 Table 124. Global Gastrointestinal Stromal Tumor Drug Sales Quantity by Type (2019-2024) & (K Units)
 Table 125. Global Gastrointestinal Stromal Tumor Drug Sales Quantity by Type (2025-2030) & (K Units)
 Table 126. Global Gastrointestinal Stromal Tumor Drug Consumption Value by Type (2019-2024) & (USD Million)
 Table 127. Global Gastrointestinal Stromal Tumor Drug Consumption Value by Type (2025-2030) & (USD Million)
 Table 128. Global Gastrointestinal Stromal Tumor Drug Average Price by Type (2019-2024) & (US$/Unit)
 Table 129. Global Gastrointestinal Stromal Tumor Drug Average Price by Type (2025-2030) & (US$/Unit)
 Table 130. Global Gastrointestinal Stromal Tumor Drug Sales Quantity by Application (2019-2024) & (K Units)
 Table 131. Global Gastrointestinal Stromal Tumor Drug Sales Quantity by Application (2025-2030) & (K Units)
 Table 132. Global Gastrointestinal Stromal Tumor Drug Consumption Value by Application (2019-2024) & (USD Million)
 Table 133. Global Gastrointestinal Stromal Tumor Drug Consumption Value by Application (2025-2030) & (USD Million)
 Table 134. Global Gastrointestinal Stromal Tumor Drug Average Price by Application (2019-2024) & (US$/Unit)
 Table 135. Global Gastrointestinal Stromal Tumor Drug Average Price by Application (2025-2030) & (US$/Unit)
 Table 136. North America Gastrointestinal Stromal Tumor Drug Sales Quantity by Type (2019-2024) & (K Units)
 Table 137. North America Gastrointestinal Stromal Tumor Drug Sales Quantity by Type (2025-2030) & (K Units)
 Table 138. North America Gastrointestinal Stromal Tumor Drug Sales Quantity by Application (2019-2024) & (K Units)
 Table 139. North America Gastrointestinal Stromal Tumor Drug Sales Quantity by Application (2025-2030) & (K Units)
 Table 140. North America Gastrointestinal Stromal Tumor Drug Sales Quantity by Country (2019-2024) & (K Units)
 Table 141. North America Gastrointestinal Stromal Tumor Drug Sales Quantity by Country (2025-2030) & (K Units)
 Table 142. North America Gastrointestinal Stromal Tumor Drug Consumption Value by Country (2019-2024) & (USD Million)
 Table 143. North America Gastrointestinal Stromal Tumor Drug Consumption Value by Country (2025-2030) & (USD Million)
 Table 144. Europe Gastrointestinal Stromal Tumor Drug Sales Quantity by Type (2019-2024) & (K Units)
 Table 145. Europe Gastrointestinal Stromal Tumor Drug Sales Quantity by Type (2025-2030) & (K Units)
 Table 146. Europe Gastrointestinal Stromal Tumor Drug Sales Quantity by Application (2019-2024) & (K Units)
 Table 147. Europe Gastrointestinal Stromal Tumor Drug Sales Quantity by Application (2025-2030) & (K Units)
 Table 148. Europe Gastrointestinal Stromal Tumor Drug Sales Quantity by Country (2019-2024) & (K Units)
 Table 149. Europe Gastrointestinal Stromal Tumor Drug Sales Quantity by Country (2025-2030) & (K Units)
 Table 150. Europe Gastrointestinal Stromal Tumor Drug Consumption Value by Country (2019-2024) & (USD Million)
 Table 151. Europe Gastrointestinal Stromal Tumor Drug Consumption Value by Country (2025-2030) & (USD Million)
 Table 152. Asia-Pacific Gastrointestinal Stromal Tumor Drug Sales Quantity by Type (2019-2024) & (K Units)
 Table 153. Asia-Pacific Gastrointestinal Stromal Tumor Drug Sales Quantity by Type (2025-2030) & (K Units)
 Table 154. Asia-Pacific Gastrointestinal Stromal Tumor Drug Sales Quantity by Application (2019-2024) & (K Units)
 Table 155. Asia-Pacific Gastrointestinal Stromal Tumor Drug Sales Quantity by Application (2025-2030) & (K Units)
 Table 156. Asia-Pacific Gastrointestinal Stromal Tumor Drug Sales Quantity by Region (2019-2024) & (K Units)
 Table 157. Asia-Pacific Gastrointestinal Stromal Tumor Drug Sales Quantity by Region (2025-2030) & (K Units)
 Table 158. Asia-Pacific Gastrointestinal Stromal Tumor Drug Consumption Value by Region (2019-2024) & (USD Million)
 Table 159. Asia-Pacific Gastrointestinal Stromal Tumor Drug Consumption Value by Region (2025-2030) & (USD Million)
 Table 160. South America Gastrointestinal Stromal Tumor Drug Sales Quantity by Type (2019-2024) & (K Units)
 Table 161. South America Gastrointestinal Stromal Tumor Drug Sales Quantity by Type (2025-2030) & (K Units)
 Table 162. South America Gastrointestinal Stromal Tumor Drug Sales Quantity by Application (2019-2024) & (K Units)
 Table 163. South America Gastrointestinal Stromal Tumor Drug Sales Quantity by Application (2025-2030) & (K Units)
 Table 164. South America Gastrointestinal Stromal Tumor Drug Sales Quantity by Country (2019-2024) & (K Units)
 Table 165. South America Gastrointestinal Stromal Tumor Drug Sales Quantity by Country (2025-2030) & (K Units)
 Table 166. South America Gastrointestinal Stromal Tumor Drug Consumption Value by Country (2019-2024) & (USD Million)
 Table 167. South America Gastrointestinal Stromal Tumor Drug Consumption Value by Country (2025-2030) & (USD Million)
 Table 168. Middle East & Africa Gastrointestinal Stromal Tumor Drug Sales Quantity by Type (2019-2024) & (K Units)
 Table 169. Middle East & Africa Gastrointestinal Stromal Tumor Drug Sales Quantity by Type (2025-2030) & (K Units)
 Table 170. Middle East & Africa Gastrointestinal Stromal Tumor Drug Sales Quantity by Application (2019-2024) & (K Units)
 Table 171. Middle East & Africa Gastrointestinal Stromal Tumor Drug Sales Quantity by Application (2025-2030) & (K Units)
 Table 172. Middle East & Africa Gastrointestinal Stromal Tumor Drug Sales Quantity by Country (2019-2024) & (K Units)
 Table 173. Middle East & Africa Gastrointestinal Stromal Tumor Drug Sales Quantity by Country (2025-2030) & (K Units)
 Table 174. Middle East & Africa Gastrointestinal Stromal Tumor Drug Consumption Value by Country (2019-2024) & (USD Million)
 Table 175. Middle East & Africa Gastrointestinal Stromal Tumor Drug Consumption Value by Country (2025-2030) & (USD Million)
 Table 176. Gastrointestinal Stromal Tumor Drug Raw Material
 Table 177. Key Manufacturers of Gastrointestinal Stromal Tumor Drug Raw Materials
 Table 178. Gastrointestinal Stromal Tumor Drug Typical Distributors
 Table 179. Gastrointestinal Stromal Tumor Drug Typical Customers


List of Figures
 Figure 1. Gastrointestinal Stromal Tumor Drug Picture
 Figure 2. Global Gastrointestinal Stromal Tumor Drug Revenue by Type, (USD Million), 2019 & 2023 & 2030
 Figure 3. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Type in 2023
 Figure 4. Imatinib Examples
 Figure 5. Sunitinib Examples
 Figure 6. Regorafenib Examples
 Figure 7. Ripretinib Examples
 Figure 8. Others Examples
 Figure 9. Global Gastrointestinal Stromal Tumor Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 10. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Application in 2023
 Figure 11. Hospital Examples
 Figure 12. Clinic Examples
 Figure 13. Others Examples
 Figure 14. Global Gastrointestinal Stromal Tumor Drug Consumption Value, (USD Million): 2019 & 2023 & 2030
 Figure 15. Global Gastrointestinal Stromal Tumor Drug Consumption Value and Forecast (2019-2030) & (USD Million)
 Figure 16. Global Gastrointestinal Stromal Tumor Drug Sales Quantity (2019-2030) & (K Units)
 Figure 17. Global Gastrointestinal Stromal Tumor Drug Price (2019-2030) & (US$/Unit)
 Figure 18. Global Gastrointestinal Stromal Tumor Drug Sales Quantity Market Share by Manufacturer in 2023
 Figure 19. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Manufacturer in 2023
 Figure 20. Producer Shipments of Gastrointestinal Stromal Tumor Drug by Manufacturer Sales ($MM) and Market Share (%): 2023
 Figure 21. Top 3 Gastrointestinal Stromal Tumor Drug Manufacturer (Revenue) Market Share in 2023
 Figure 22. Top 6 Gastrointestinal Stromal Tumor Drug Manufacturer (Revenue) Market Share in 2023
 Figure 23. Global Gastrointestinal Stromal Tumor Drug Sales Quantity Market Share by Region (2019-2030)
 Figure 24. Global Gastrointestinal Stromal Tumor Drug Consumption Value Market Share by Region (2019-2030)
 Figure 25. North America Gastrointestinal Stromal Tumor Drug Consumption Value (2019-2030) & (USD Million)
 Figure 26. Europe Gastrointestinal Stromal Tumor Drug Consumption Value (2019-2030) & (USD Million)
 Figure 27. Asia-Pacific Gastrointestinal Stromal Tumor Drug Consumption Value (2019-2030) & (USD Million)
 Figure 28. South America Gastrointestinal Stromal Tumor Drug Consumption Value (2019-2030) & (USD Million)
 Figure 29. Middle East & Africa Gastrointestinal Stromal Tumor Drug Consumption Value (2019-2030) & (USD Million)
 Figure 30. Global Gastrointestinal Stromal Tumor Drug Sales Quantity Market Share by Type (2019-2030)
 Figure 31. Global Gastrointestinal Stromal Tumor Drug Consumption Value Market Share by Type (2019-2030)
 Figure 32. Global Gastrointestinal Stromal Tumor Drug Average Price by Type (2019-2030) & (US$/Unit)
 Figure 33. Global Gastrointestinal Stromal Tumor Drug Sales Quantity Market Share by Application (2019-2030)
 Figure 34. Global Gastrointestinal Stromal Tumor Drug Revenue Market Share by Application (2019-2030)
 Figure 35. Global Gastrointestinal Stromal Tumor Drug Average Price by Application (2019-2030) & (US$/Unit)
 Figure 36. North America Gastrointestinal Stromal Tumor Drug Sales Quantity Market Share by Type (2019-2030)
 Figure 37. North America Gastrointestinal Stromal Tumor Drug Sales Quantity Market Share by Application (2019-2030)
 Figure 38. North America Gastrointestinal Stromal Tumor Drug Sales Quantity Market Share by Country (2019-2030)
 Figure 39. North America Gastrointestinal Stromal Tumor Drug Consumption Value Market Share by Country (2019-2030)
 Figure 40. United States Gastrointestinal Stromal Tumor Drug Consumption Value (2019-2030) & (USD Million)
 Figure 41. Canada Gastrointestinal Stromal Tumor Drug Consumption Value (2019-2030) & (USD Million)
 Figure 42. Mexico Gastrointestinal Stromal Tumor Drug Consumption Value (2019-2030) & (USD Million)
 Figure 43. Europe Gastrointestinal Stromal Tumor Drug Sales Quantity Market Share by Type (2019-2030)
 Figure 44. Europe Gastrointestinal Stromal Tumor Drug Sales Quantity Market Share by Application (2019-2030)
 Figure 45. Europe Gastrointestinal Stromal Tumor Drug Sales Quantity Market Share by Country (2019-2030)
 Figure 46. Europe Gastrointestinal Stromal Tumor Drug Consumption Value Market Share by Country (2019-2030)
 Figure 47. Germany Gastrointestinal Stromal Tumor Drug Consumption Value (2019-2030) & (USD Million)
 Figure 48. France Gastrointestinal Stromal Tumor Drug Consumption Value (2019-2030) & (USD Million)
 Figure 49. United Kingdom Gastrointestinal Stromal Tumor Drug Consumption Value (2019-2030) & (USD Million)
 Figure 50. Russia Gastrointestinal Stromal Tumor Drug Consumption Value (2019-2030) & (USD Million)
 Figure 51. Italy Gastrointestinal Stromal Tumor Drug Consumption Value (2019-2030) & (USD Million)
 Figure 52. Asia-Pacific Gastrointestinal Stromal Tumor Drug Sales Quantity Market Share by Type (2019-2030)
 Figure 53. Asia-Pacific Gastrointestinal Stromal Tumor Drug Sales Quantity Market Share by Application (2019-2030)
 Figure 54. Asia-Pacific Gastrointestinal Stromal Tumor Drug Sales Quantity Market Share by Region (2019-2030)
 Figure 55. Asia-Pacific Gastrointestinal Stromal Tumor Drug Consumption Value Market Share by Region (2019-2030)
 Figure 56. China Gastrointestinal Stromal Tumor Drug Consumption Value (2019-2030) & (USD Million)
 Figure 57. Japan Gastrointestinal Stromal Tumor Drug Consumption Value (2019-2030) & (USD Million)
 Figure 58. South Korea Gastrointestinal Stromal Tumor Drug Consumption Value (2019-2030) & (USD Million)
 Figure 59. India Gastrointestinal Stromal Tumor Drug Consumption Value (2019-2030) & (USD Million)
 Figure 60. Southeast Asia Gastrointestinal Stromal Tumor Drug Consumption Value (2019-2030) & (USD Million)
 Figure 61. Australia Gastrointestinal Stromal Tumor Drug Consumption Value (2019-2030) & (USD Million)
 Figure 62. South America Gastrointestinal Stromal Tumor Drug Sales Quantity Market Share by Type (2019-2030)
 Figure 63. South America Gastrointestinal Stromal Tumor Drug Sales Quantity Market Share by Application (2019-2030)
 Figure 64. South America Gastrointestinal Stromal Tumor Drug Sales Quantity Market Share by Country (2019-2030)
 Figure 65. South America Gastrointestinal Stromal Tumor Drug Consumption Value Market Share by Country (2019-2030)
 Figure 66. Brazil Gastrointestinal Stromal Tumor Drug Consumption Value (2019-2030) & (USD Million)
 Figure 67. Argentina Gastrointestinal Stromal Tumor Drug Consumption Value (2019-2030) & (USD Million)
 Figure 68. Middle East & Africa Gastrointestinal Stromal Tumor Drug Sales Quantity Market Share by Type (2019-2030)
 Figure 69. Middle East & Africa Gastrointestinal Stromal Tumor Drug Sales Quantity Market Share by Application (2019-2030)
 Figure 70. Middle East & Africa Gastrointestinal Stromal Tumor Drug Sales Quantity Market Share by Country (2019-2030)
 Figure 71. Middle East & Africa Gastrointestinal Stromal Tumor Drug Consumption Value Market Share by Country (2019-2030)
 Figure 72. Turkey Gastrointestinal Stromal Tumor Drug Consumption Value (2019-2030) & (USD Million)
 Figure 73. Egypt Gastrointestinal Stromal Tumor Drug Consumption Value (2019-2030) & (USD Million)
 Figure 74. Saudi Arabia Gastrointestinal Stromal Tumor Drug Consumption Value (2019-2030) & (USD Million)
 Figure 75. South Africa Gastrointestinal Stromal Tumor Drug Consumption Value (2019-2030) & (USD Million)
 Figure 76. Gastrointestinal Stromal Tumor Drug Market Drivers
 Figure 77. Gastrointestinal Stromal Tumor Drug Market Restraints
 Figure 78. Gastrointestinal Stromal Tumor Drug Market Trends
 Figure 79. Porters Five Forces Analysis
 Figure 80. Manufacturing Cost Structure Analysis of Gastrointestinal Stromal Tumor Drug in 2023
 Figure 81. Manufacturing Process Analysis of Gastrointestinal Stromal Tumor Drug
 Figure 82. Gastrointestinal Stromal Tumor Drug Industrial Chain
 Figure 83. Sales Channel: Direct to End-User vs Distributors
 Figure 84. Direct Channel Pros & Cons
 Figure 85. Indirect Channel Pros & Cons
 Figure 86. Methodology
 Figure 87. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Novartis
Bayer Pharmaceuticals
Glenmark Pharmaceuticals Ltd.
Sun Pharmaceuticals
Actavis Generics
Dr. Reddy's Laboratories
Teva Pharmaceutical Industries Ltd.
Apotex Inc.
Mylan Pharms Inc.
Bulat Pharmaceutical
MSN Laboratories
Vannsh Life Sciences
Beacon Pharmaceuticals
Drug International
Deciphera Pharmaceuticals
CSPC Pharmaceuticals
Hansoh Pharmaceuticals
Kelun Pharmaceuticals
Zai Lab
CStone Pharmaceuticals
China Biopharmaceuticals

Related Reports

Global Gastrointestinal Stromal Tumor Drug Supply, Demand and Key Producers, 2024-2030

Global Gastrointestinal Stromal Tumor Drug Supply, Demand and Key Producers, 2024-2030

date 29 Jul 2024

date Pharma & Healthcare

The global Gastrointestinal Stromal Tumor Drug market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).

Product Tags

Gastrointestinal Stromal Tumor Drug

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>